BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1716542)

  • 21. CD19+CD5+ B cells in primary IgA nephropathy.
    Yuling H; Ruijing X; Xiang J; Yanping J; Lang C; Li L; Dingping Y; Xinti T; Jingyi L; Zhiqing T; Yongyi B; Bing X; Xinxing W; Youxin J; Fox DA; Lundy SK; Guohua D; Jinquan T
    J Am Soc Nephrol; 2008 Nov; 19(11):2130-9. PubMed ID: 18650480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells.
    Brezinschek HP; Foster SJ; Brezinschek RI; Dörner T; Domiati-Saad R; Lipsky PE
    J Clin Invest; 1997 May; 99(10):2488-501. PubMed ID: 9153293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD5+ B lymphocytes and T-cell subsets in a case of juvenile rheumatoid arthritis.
    Ambrogi F; Ricciardi L; Nutini P; Vanacore R
    Ann N Y Acad Sci; 1992 May; 651():564-9. PubMed ID: 1376077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
    Waddick KG; Uckun FM
    Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B cell number and function in Graves' disease.
    Wilson R; Pearson C; McKillop JH; Thomson JA
    Autoimmunity; 1994; 17(3):251. PubMed ID: 7524703
    [No Abstract]   [Full Text] [Related]  

  • 26. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
    Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
    J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective expression of a VHIV subfamily of immunoglobulin genes in human CD5+ B lymphocytes from cord blood.
    Mageed RA; MacKenzie LE; Stevenson FK; Yuksel B; Shokri F; Maziak BR; Jefferis R; Lydyard PM
    J Exp Med; 1991 Jul; 174(1):109-13. PubMed ID: 1711557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases.
    Markeljević J; Batinić D; Uzarević B; Bozikov J; Cikes N; Babić-Naglić D; Horvat Z; Marusić M
    J Rheumatol; 1994 Dec; 21(12):2225-30. PubMed ID: 7535356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparative isolation of murine CD5 B cells by panning and magnetic beads.
    Metzger DW; Metzger CA; Ling LA; Hurst JS; Van Cleave VH
    Ann N Y Acad Sci; 1992 May; 651():75-7. PubMed ID: 1376090
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of combination antiretroviral therapy on CD5 B- cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients.
    Redgrave BE; Stone SF; French MA; Krueger R; James IR; Price P
    HIV Med; 2005 Sep; 6(5):307-12. PubMed ID: 16156877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD5+ B cells and naturally occurring autoantibodies in cancer patients.
    Stein R; Witz IP; Ovadia J; Goldenberg DM; Yron I
    Clin Exp Immunol; 1991 Sep; 85(3):418-23. PubMed ID: 1716541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD5+ B cells in normal newborns and infants, and in those with HIV and intrauterine infections.
    Ibegbu CC; Nahmias AJ; Spira TJ; Stoll BJ; Jones B; Symbas N; Nesheim S; Mendez H; Keyserling H; Lee FK
    Ann N Y Acad Sci; 1992 May; 651():572-5. PubMed ID: 1376079
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-Pneumococcal Capsular Polysaccharide Antibody Response and CD5 B Lymphocyte Subsets.
    Moens L; Verbinnen B; Covens K; Wuyts G; Johnson M; Roalfe L; Goldblatt D; Meyts I; Bossuyt X
    Infect Immun; 2015 Jul; 83(7):2889-96. PubMed ID: 25939510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets.
    Ekşioglu-Demiralp E; Kibaroglu A; Direskeneli H; Yavuz S; Karsli F; Yurdakul S; Yazici H; Akoglu T
    J Rheumatol; 1999 Apr; 26(4):826-32. PubMed ID: 10229403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation.
    Fischer M; Klein U; Küppers R
    J Clin Invest; 1997 Oct; 100(7):1667-76. PubMed ID: 9312164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRC OX19 recognizes the rat CD5 surface glycoprotein, but does not provide evidence for a population of CD5bright B cells.
    Vermeer LA; de Boer NK; Bucci C; Bos NA; Kroese FG; Alberti S
    Eur J Immunol; 1994 Mar; 24(3):585-92. PubMed ID: 7510236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-grade non-Hodgkin's lymphoma in a patient with systemic lupus erythematosus.
    Robak T; Robak E; Bartkowiak J; Błoński JZ; Niewiadomska H; Wawrzyniak E
    Leuk Lymphoma; 2001 May; 41(5-6):659-67. PubMed ID: 11378584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways.
    Cong YZ; Rabin E; Wortis HH
    Int Immunol; 1991 May; 3(5):467-76. PubMed ID: 1716972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraclonal diversity in the VH genes expressed by CD5- chronic lymphocytic leukemia-producing pathologic IgM rheumatoid factor.
    Roudier J; Silverman GJ; Chen PP; Carson DA; Kipps TJ
    J Immunol; 1990 Feb; 144(4):1526-30. PubMed ID: 1689356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.